Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABCL | AZN | AMGN | GILD | VRTX |
| Company | Abcellera Biologics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.56 | 69.65 | 279.47 | 102.68 | 492.54 |
| High | 2.64 | 69.79 | 282.19 | 104.20 | 494.92 |
| Low | 2.54 | 68.80 | 276.44 | 93.37 | 484.50 |
| Last | 2.57 | 69.57 | 280.84 | 103.17 | 493.84 |
| Change | -0.03 | +0.02 | +1.00 | -2.98 | +1.37 |
| % Change | -1.15% | +0.03% | +0.36% | -2.81% | +0.28% |
| Volume | 2,977,100 | 6,662,700 | 1,994,600 | 14,208,199 | 1,561,500 |
| 20-Day Average Volume | 4,221,145 | 6,741,980 | 3,237,410 | 9,842,250 | 1,713,890 |
| Previous Close | 2.60 | 69.55 | 279.84 | 106.15 | 492.47 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.30 | 68.80 | 290.18 | 106.64 | 485.57 |
| 20-Day Raw Stochastic | 86.08% | 57.61% | 28.24% | 45.84% | 80.67% |
| 20-Day Relative Strength | 53.57% | 47.57% | 42.30% | 43.92% | 53.41% |
| Weighted Alpha | -28.81 | -9.06 | -2.29 | +52.54 | +20.77 |
| Today's Opinion | 40% Sell | 56% Sell | 56% Sell | 40% Buy | 56% Buy |
| Previous Opinion | 40% Sell | 56% Sell | 56% Sell | 40% Buy | 56% Buy |
| Last Month's Opinion | 56% Sell | 24% Sell | 16% Buy | 80% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.20% since 04/17/25 | +2.93% since 04/17/25 | +1.28% since 04/17/25 | -1.31% since 04/17/25 | +0.97% since 04/17/25 |
| Low | 2.31 on 04/21/25 | 66.59 on 04/21/25 | 270.36 on 04/21/25 | 93.37 on 04/25/25 | 472.90 on 04/21/25 |
| High | 2.68 on 04/23/25 | 69.79 on 04/25/25 | 283.60 on 04/23/25 | 107.56 on 04/24/25 | 498.41 on 04/23/25 |
| 1-Month | |||||
| %Chg | +1.58% since 03/25/25 | -4.76% since 03/25/25 | -8.48% since 03/25/25 | -4.37% since 03/25/25 | -2.99% since 03/25/25 |
| Low | 1.89 on 04/07/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 448.14 on 04/07/25 |
| High | 2.68 on 04/23/25 | 75.70 on 04/03/25 | 315.00 on 03/31/25 | 114.75 on 04/03/25 | 508.64 on 03/26/25 |
| 3-Month | |||||
| %Chg | -26.15% since 01/24/25 | +0.74% since 01/24/25 | +1.97% since 01/24/25 | +10.85% since 01/24/25 | +12.33% since 01/24/25 |
| Low | 1.89 on 04/07/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.10 on 01/27/25 | 430.81 on 01/29/25 |
| High | 3.60 on 02/18/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -5.51% since 10/25/24 | -7.30% since 10/25/24 | -11.40% since 10/25/24 | +15.92% since 10/25/24 | +3.38% since 10/25/24 |
| Low | 1.89 on 04/07/25 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 86.08 on 11/19/24 | 377.85 on 12/19/24 |
| High | 3.68 on 01/22/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 622,795 | 212,311,376 | 158,279,088 | 133,543,728 | 121,877,672 |
| Shares Outstanding, K | 297,988 | 3,101,247 | 537,651 | 1,245,163 | 256,790 |
| Annual Sales | 28,830,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -162,860,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 5,050,000 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -34,210,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 0.50 | 0.49 | 0.59 | 0.32 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 02/27/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.81 on 04/24/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 05/08/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.93 | 14.17 | 13.33 | 0.00 |